FastWave Medical kicks off first-in-human study of its IVL tech

FastWave Medical announced the successful completion of enrollment for its first-in-human study of its peripheral intravascular lithotripsy (IVL) system to treat calcified cardiovascular disease.

Dr. Miguel Montero-Baker of Houston Methodist Hospital and the Hope Vascular & Podiatry Clinic and Dr. Venkatesh Ramaiah of HonorHealth Vascular Group and the Pulse Cardiovascular Institute successfully conducted the procedures with the hosting investigator, Dr. Antonio Muñoa.

“I am excited to be part of the initial cases to evaluate FastWave’s peripheral IVL platform. Their team has rapidly developed an easy-to-use system to address existing technological gaps, marking a significant milestone in achieving the company’s near-term goals,” Montero-Baker said in a news release.

Minneapolis-based FastWave’s IVL platform is meant to treat calcific artery disease by fracturing calcium deposits with a balloon catheter that deliversshoc…

Read more
  • 0

FastWave Medical closes fundraising round

FastWave Medical announced that it closed an oversubscribed, multi-million-dollar private financing round.

The Minneapolis-based medical device company says the financing — secured in just a few weeks — highlights the growing interest in its offerings. FastWave develops systems for multiple intravascular lithotripsy (IVL).

“Since the inception of our company, we’ve received considerable inbound interest from potential investors,” said Scott Nelson, FastWave co-founder and CEO. “But when we opened up this private placement, we were blown away by the response. This financial milestone, combined with the speed at which our engineering team is moving, underscores FastWave’s momentum in the IVL space.”

Founded two and a half years ago, FastWave aims to address the challenges of artery calcification through differentiated IVL platforms. Its multiple systems could provide physicians with more treatment options that are econ…

Read more
  • 0

Redefining the treatment of artery disease with advanced intravascular lithotripsy

Device developer FastWave Medical is working to advance intravascular lithotripsy therapy for peripheral and coronary artery disease.

FastWave Medical’s intravascular lithotripsy (IVL) device [Illustration courtesy of FastWave Medical]

By Tristan Tieso, FastWave Medical

Cardiovascular disease, including peripheral artery disease (PAD) and coronary artery disease (CAD), affects millions of people worldwide. Resulting from obstruction in one or more arteries, these conditions are often complicated by the presence of calcified plaque.

The prevalence of arterial disease has profound implications for society. Patients experience physical limitations like reduced mobility and discomfort, all of which directly impact their daily activities and independence. There’s also the economic strain these diseases put on patients and healthcare systems due to the long-term nature of treatment.

Advances in me…

Read more
  • 0

FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical

FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings.

Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory initiatives for its endovascular therapies to treat calcific artery disease.

Get the full story on our sister site, Medical Tubing + Extrusion.

Read more
  • 0